Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same
    1.
    发明公开
    Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same 失效
    的哌啶衍生物,处理其制备以及含有该药物组合物。

    公开(公告)号:EP0399414A1

    公开(公告)日:1990-11-28

    申请号:EP90109534.9

    申请日:1990-05-19

    CPC分类号: C07D211/54 C07D211/46

    摘要: A piperidine derivative represented by the following general formula (I):
    wherein R₁ and R₂ are the same or different and each independently represents a hydrogen atom, a halogen atom, a lower alkyl group, or a lower alkoxy group; R₃ represents a hydrogen atom or a lower alkyl group; X represents an oxygen atom or a sulfur atom; Y represents an alkylene group having 1 to 7 carbon atoms which may be optionally substituted with a lower alkyl group, or Y represents an -A-O-B- group wherein A and B are the same or different and each independently represents an alkylene group having 1 to 3 carbon atoms which may be optionally substituted with a lower alkyl group is disclosed. Also disclosed are a pharmacologically acceptable salt of a compound of formula (I), an antihistaminic and antiallergic agent comprising a compound of formula (I), a pharmaceutical composition comprising a compound of formula (I), and a method for the treatment of an allergic disease by administering a compound of formula (I).

    摘要翻译: 由下述通式(I)表示的哌啶衍生物: worin R1和R2是相同或不同,并且各自unabhängigdarstellt氢原子,卤原子,低级烷基,或低级烷氧基; R 3表示氢原子或低级烷基; X darstellt到氧原子或硫原子; 具有可任选被低级烷基,或Y darstellt substituiertem到-AOB-组worin A和B是相同的或不同的,并且具有1至3的亚烷基基团的每个unabhängigdarstellt 1至7个碳原子的亚烷基基团Y的darstellt 这可能与低级烷基,任选地substituiertem碳原子是游离缺失盘。 所以游离缺失盘是式(I)中,在抗组胺和抗过敏剂,其包含式(I)的化合物的化合物,的药理学上可接受的盐的药物组合物包含式(I)的化合物,和用于的治疗的方法 通过施用式(I)的化合物的过敏性疾病。

    Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same
    3.
    发明公开
    Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same 失效
    哌啶衍生物,其制备方法和药物组合物。

    公开(公告)号:EP0406739A2

    公开(公告)日:1991-01-09

    申请号:EP90112533.6

    申请日:1990-06-30

    CPC分类号: C07D405/04 C07D211/70

    摘要: A piperidine derivative represented by the following general formula (I):

    wherein R represents a hydrogen atom or a lower alkyl group; X represent -CH=CH-, -CH₂CH₂-, or -CH₂O-; Y represent an alkylene group having 1 to 5 carbon atoms which may be optionally substituted with a lower alkyl group, or Y represents an -A-O-B- group wherein A and B are the same or different and each independently represents and alkylene group having 1 to 3 carbon atoms which may be optionally substituted with a lower alkyl group is disclosed. Also disclosed are a pharmacologically acceptable salt of a compound of formula (I), a method for preparation of a compound of formula (I), an antihistaminic and antiallergic agent comprising a compound of formula (I), and a method for the treatment of an allergic disease by administering a compound of formula (I).

    摘要翻译: 由下述通式(I)表示的哌啶衍生物: worinřdarstellt一个氢原子或一个低级烷基; X代表-CH = CH-,-CH 2 CH 2,或-CH 2 O-; Y为具有在其可以任选被低级烷基,或Y darstellt substituiertem到-AOB-组worin A和B是相同的或不同的,并且具有1至3各自unabhängigdarstellt和亚烷基基团含1-5个碳原子的亚烷基团 这可能与低级烷基,任选地substituiertem碳原子是游离缺失盘。 所以游离缺失盘是式(I)中,用于制备式(I)的化合物的方法,包括式(I)的化合物的化合物在抗组胺和抗过敏剂的药理学上可接受的盐,以及用于治疗的方法 通过施用式(I)的化合物的过敏性疾病的。

    Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same
    9.
    发明公开
    Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same 失效
    哌啶衍生物,其制备方法和包含其的药物组合物

    公开(公告)号:EP0406739A3

    公开(公告)日:1992-02-26

    申请号:EP90112533.6

    申请日:1990-06-30

    CPC分类号: C07D405/04 C07D211/70

    摘要: A piperidine derivative represented by the following general formula (I):

    wherein R represents a hydrogen atom or a lower alkyl group; X represent -CH=CH-, -CH₂CH₂-, or -CH₂O-; Y represent an alkylene group having 1 to 5 carbon atoms which may be optionally substituted with a lower alkyl group, or Y represents an -A-O-B- group wherein A and B are the same or different and each independently represents and alkylene group having 1 to 3 carbon atoms which may be optionally substituted with a lower alkyl group is disclosed. Also disclosed are a pharmacologically acceptable salt of a compound of formula (I), a method for preparation of a compound of formula (I), an antihistaminic and antiallergic agent comprising a compound of formula (I), and a method for the treatment of an allergic disease by administering a compound of formula (I).